Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/11/14
End: 05/08/17
Due: 05/08/18
Phase: N/A
Priority: Normal
Start: 02/26/21
End: 03/11/21
Due: 03/11/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria | NCT03477422 | Venus Remedies Limited | user2@example.com | None | 2014-01-11 | 2017-05-08 | 2018-05-08 | - | - | 2025-07-14 |
| Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects | NCT05265676 | Venus Remedies Limited | user2@example.com | None | 2021-02-26 | 2021-03-11 | 2022-03-11 | - | - | 2025-07-14 |